Stryker Rejuvenate Hip Implant Lawsuit: Planned Settlement Amount Increased to $1 Billion

stryker hip implant lawyer

FREE CASE EVALUATION: PLEASE CALL 1-800-632-1404

Stryker Corporation plans to pay around $1 billion to settle over 1,100 ABG II and Rejuvenate hip implant lawsuits filed across the United States. According to the quarterly financial disclosures by the hip implant system manufacturer, it is expected to pay $700 million to $1.13 billion in compensation to settle the growing number of litigations filed by people suffering due to the abrupt failure and other side effects of its hip implant systems. The Michigan-based firm had in 2012 earmarked expected payments between $400 and $660 million to pay damages to the victims of its defective hip implants.

The planned compensation is expected to overshadow $1 billion paid by Sulzer to settle about 7,000 hip implant litigations in 2001 and become the second highest settlement, preceded only by $2.5 billion settlement planned by Johnson & Johnson for its DePuy hip implants.

Stryker Rejuvenate Hip Implant Lawsuit: The Recall and Side Effects

Stryker Rejuvenate hip implant devices were removed from the market in July 2012 following large-scale consumer complaints linking them to corrosion, early failure, and metal toxicity. The manufacture claimed that “potential fretting and/or corrosion at or about the modular-neck junction, which may result in adverse local tissue reactions manifesting with pain and/or swelling” led to the recall.

The recall was a foregone conclusion with thousands of consumers complaining about serious injuries and side effects of Stryker Rejuvenate hip implants. The FDA received as many as 60 injury complaints in the six months preceding the recall. The following are the most common side effects and injuries caused by Stryker Rejuvenate hip implants.

  • Early Failure: Stryker Rejuvenate hip implants are expected to last for 15 to 20 years. However, most of the complainants suffered injuries due to its sudden and premature break down within two to three years.
  • Fast Erosion: Stryker Rejuvenate hip implant lawsuits claim that the defective design of the device results in fast erosion and fretting, a key reason for its early failure.
  • Loosening and Corrosion: The design defect causes metal parts of the Stryker Rejuvenate hip implants to wear away and loosen.
  • Metal Toxicity: A high rate of corrosion and friction results in release of metal parts into the user blood – which causes the risk of metal toxicity.

Other Stryker Rejuvenate hip implant injuries include bone necrosis, pain, hypersensitivity, and inflammatory reactions. Victims are also required to undergo secondary hip surgery.

Stryker Rejuvenate Hip Implant Lawsuit: An Update

More than 450 Stryker hip implant lawsuits are centralized by the federal MDL panel at the court of Minnesota District Judge Donovan Frank. About 600 Stryker hip implant lawsuits are pending for trial in the New Jersey state courts. The state supreme court has selected Bergen County Judge Brian Martinotti to head the pretrial consolidation process.

The number of Stryker Rejuvenate hip implant lawsuits is expected to swell, as over five percent of 20,000 consumers implanted with its hip systems are already filed with the court claiming injuries. The lawsuits claim that Stryker introduced defective Rejuvenate hip implants with false claims and without adequate testing and warning about injuries associated with it.

In August 2013, Judge Martinotti of New Jersey set the stage for mediation with the selection of 10 Stryker Rejuvenate hip implant lawsuits for bellwether trial. In December 2013, Stryker settled four of hip implant lawsuits filed in New Jersey without disclosing the compensation amount paid to the plaintiffs. But the two more deals negotiated fell through.

About Our Firm

Our team of medical device and pharmaceutical drug attorneys will provide you with a  free case evaluation on your case. Please call us or fill out this information in order for us to try and help you. We also are proud to accept medical device and pharmaceutical drug cases on a contingency basis, meaning that we do not accept a fee if there is no recovery via settlement or judgment. We also front all expenses of litigation meaning you do not have to pay us anything out of pocket and only pay us when you obtain a recovery.

For a free case evaluation, please contact:

TOLL FREE: 1-800-632-1404

FILL OUT THIS FORM:

    Your Name (required)

    Your Email (required)

    Your Phone Number (required)

    Case Details

    captcha

    NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.

    Leave a Reply

    Your email address will not be published. Required fields are marked *